 copy.png)
CyGenica aims to transform the intracellular drug delivery landscape through strategic partnerships with visionary biopharmaceutical companies worldwide.
We seek partnerships with biopharmaceutical companies that share our vision for advancing therapeutic delivery. Our ideal partners are those developing innovative treatments, particularly in siRNA, ASO, protein-based drugs, genome editing therapies, gene therapies, and CAR-T cell therapies.
.jpg)
Traditional delivery systems often result in therapeutic molecules being trapped in endosomes, reducing their effectiveness. GEENIE ensures that 100% of the therapeutic payload reaches the intracellular target site.
.jpg)
Delivering drugs across the BBB is a significant hurdle for neurological diseases. GEENIE's unique design facilitates this delivery, expanding treatment options for previously inaccessible conditions.
.jpg)
By enhancing solubility, GEENIE can revive shelved drugs and make them viable again.
GEENIE is Guided, Efficient, and Effortless Navigation
By partnering with CyGenica, companies can leverage the benefits of GEENIE technology to enhance their therapeutic pipelines. For more information on how GEENIE improves therapeutic efficacy, reduces toxicity, and accelerates development, please visit our Science page.
To explore partnership and collaboration opportunities, kindly reach out to our team via partnering@cygenica.com
Chief Executive Officer and Chairman of the Board
